Kirban Michael 4
4 · Vita Coco Company, Inc. · Filed May 1, 2026
Research Summary
AI-generated summary of this filing
Vita Coco (COCO) Executive Chairman Michael Kirban Sells 50,000 Shares
What Happened Michael Kirban, Executive Chairman and a director of Vita Coco (COCO), sold 50,000 shares on April 30, 2026 at $68.00 per share, generating proceeds of $3,400,000. The filing lists the transaction as an open-market or private sale and is reported on a Form 4 filed May 1, 2026.
Key Details
- Transaction date and price: 2026-04-30, 50,000 shares at $68.00 each.
- Total proceeds: $3,400,000.
- Transaction type: Sale (S); reported as open market/private sale.
- Plan/authorization: Sale effected pursuant to a Rule 10b5-1 trading plan (footnote F1).
- Shares sold were held in trusts associated with Kirban (Michael Kirban Revocable Trust and Michael Kirban 2010 Trust; footnotes F2–F3).
- Shares owned after transaction: not disclosed in the provided excerpt.
- Filing: Form 4 filed 2026-05-01 covering the 2026-04-30 transaction; no late filing indicated in the summary provided.
- Additional footnotes (F4–F8) reference vesting schedules for outstanding options but do not appear to relate directly to this sale.
Context A 10b5-1 plan lets insiders sell pre-scheduled amounts regardless of later company news, so such sales are often routine and not an immediate signal about company prospects. This was a straightforward disposal of shares by Kirban (through trusts), not an exercise or award; retail investors should view the trade as a liquidity event rather than definitive insider sentiment.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-04-30$68.00/sh−50,000$3,400,000→ 515,681 total(indirect: by M. Kirban Revoc)
- 143,799
Common Stock
- 1,479,049(indirect: by M. Kirban 2010)
Common Stock
[F3] - 546,000
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $10.18Exp: 2029-12-16→ Common Stock (546,000 underlying) - 40,950
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $10.18Exp: 2031-01-11→ Common Stock (40,950 underlying) - 298,507
Non-Qualified Stock Option (Right to Buy)
[F5]Exercise: $15.00Exp: 2031-10-21→ Common Stock (298,507 underlying) - 46,875
Non-Qualified Stock Option (Right to Buy)
[F6]Exercise: $16.91Exp: 2033-03-10→ Common Stock (46,875 underlying) - 185,133
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $16.91Exp: 2033-03-10→ Common Stock (185,133 underlying) - 62,743
Non-Qualified Stock Option (Right to Buy)
[F7]Exercise: $26.18Exp: 2034-03-04→ Common Stock (62,743 underlying) - 70,715
Non-Qualified Stock Option (Right to Buy)
[F8]Exercise: $32.78Exp: 2035-03-03→ Common Stock (70,715 underlying)
Footnotes (8)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]These shares are held by the Michael Kirban Revocable Trust.
- [F3]These shares are held by the Michael Kirban 2010 Trust.
- [F4]The stock option is fully vested and currently exercisable.
- [F5]The stock option vests in four equal annual installments beginning on November 27, 2022.
- [F6]The stock option vests in four equal annual installments beginning on March 10, 2024.
- [F7]The stock option vests in four equal annual installments beginning on March 4, 2025.
- [F8]The Stock Option vests in four equal annual installments beginning in March 3, 2026.